Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

British American Tobacco p.l.c (BTI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for British American Tobacco p.l.c (BTI) over the last 11 years, with Q4 2025 value amounting to $5.1 billion.

  • British American Tobacco p.l.c's Cash & Equivalents fell 2513.22% to $5.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.1 billion, marking a year-over-year decrease of 2513.22%. This contributed to the annual value of $5.0 billion for FY2025, which is 2546.5% down from last year.
  • British American Tobacco p.l.c's Cash & Equivalents amounted to $5.1 billion in Q4 2025, which was down 2513.22% from $5.9 billion recorded in Q2 2025.
  • In the past 5 years, British American Tobacco p.l.c's Cash & Equivalents ranged from a high of $7.5 billion in Q2 2024 and a low of $3.8 billion during Q4 2021
  • Over the past 5 years, British American Tobacco p.l.c's median Cash & Equivalents value was $4.8 billion (recorded in 2023), while the average stood at $5.2 billion.
  • In the last 5 years, British American Tobacco p.l.c's Cash & Equivalents plummeted by 2908.15% in 2021 and then surged by 6260.49% in 2024.
  • Over the past 5 years, British American Tobacco p.l.c's Cash & Equivalents (Quarter) stood at $3.8 billion in 2021, then increased by 6.74% to $4.0 billion in 2022, then surged by 43.06% to $5.8 billion in 2023, then rose by 17.57% to $6.8 billion in 2024, then dropped by 25.13% to $5.1 billion in 2025.
  • Its Cash & Equivalents was $5.1 billion in Q4 2025, compared to $5.9 billion in Q2 2025 and $6.8 billion in Q4 2024.